Karpus Management, Inc. Tekla Life Sciences Investors Transaction History
Karpus Management, Inc.
- $2.77 Billion
- Q4 2024
A detailed history of Karpus Management, Inc. transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Karpus Management, Inc. holds 489,572 shares of HQL stock, worth $6.78 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
489,572
Previous 468,598
4.48%
Holding current value
$6.78 Million
Previous $7.07 Million
9.1%
% of portfolio
0.23%
Previous 0.23%
Shares
8 transactions
Others Institutions Holding HQL
# of Institutions
78Shares Held
9.65MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.43MShares$47.5 Million1.11% of portfolio
-
Penserra Capital Management LLC Orinda, CA828KShares$11.5 Million0.2% of portfolio
-
Sit Investment Associates Inc Minneapolis, MN417KShares$5.78 Million0.12% of portfolio
-
Absolute Investment Advisers LLC400KShares$5.53 Million0.67% of portfolio
-
Morgan Stanley New York, NY366KShares$5.06 Million0.0% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...